Phase Ib trial of DMI 9523 in osteoarthritis of the knee.
Phase of Trial: Phase I
Latest Information Update: 30 Apr 2012
At a glance
- Drugs Corticosteroids; DMI 9523; Lidocaine
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms AIK
- 30 Apr 2012 Results published in an Ampio Pharmaceuticals media release.
- 03 Jan 2012 Status changed from recruiting to active, no longer recruiting.
- 26 Oct 2011 Status changed from active, no longer recruiting to recruiting.